ALL, Childhood Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about ALL, Childhood clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1Phase 2

Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia

ALL, Childhood B-CellAcute Lymphoid Leukemia RelapseAcute Lymphocytic Leukemia Refractory
University Hospital Tuebingen20 enrolled11 locationsNCT05366218
Recruiting
Phase 1

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

LymphomaMDSHematologic Malignancy+2 more
St. Jude Children's Research Hospital18 enrolled1 locationNCT06326463
Recruiting

Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

Pediatric CancerToxicity, DrugALL, Childhood+5 more
University of Geneva, Switzerland556 enrolled2 locationsNCT05512169
Recruiting
Phase 1

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

Acute Lymphoblastic LeukemiaALLALL, Childhood
University of Chicago15 enrolled1 locationNCT03571321
Recruiting

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

ALL, ChildhoodBehavior, Health
University of Kansas Medical Center46 enrolled2 locationsNCT06050850
Recruiting

Childhood Cancer Survivors' Affective Response to Exercise

Acute Lymphoblastic LeukemiaALL, Childhood
St. Jude Children's Research Hospital125 enrolled1 locationNCT05763290
Recruiting
Phase 2

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

B-cell Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-Cell ALL, Childhood
Medical College of Wisconsin25 enrolled1 locationNCT04746209